Mirae Asset Global ETFs Holdings
SGMO

Mirae Asset Global ETFs Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.2K Buy
361,277
+13,239
+4% +$5.27K ﹤0.01% 2714
2025
Q4 		$146K Buy
348,038
+148,136
+74% +$78.5K ﹤0.01% 2491
2025
Q3 		$135K Sell
199,902
-6,741
-3% -$3.63K ﹤0.01% 2529
2025
Q2 		$112K Sell
206,643
-82,992
-29% -$49.3K ﹤0.01% 2556
2025
Q1 		$190K Sell
289,635
-38,429
-12% -$40.7K ﹤0.01% 2349
2024
Q4 		$353K Buy
+328,064
New +$600K ﹤0.01% 2089
2024
Q3 		– Sell
-74,842
Closed -$26.8K – 3173
2024
Q2 		$26.8K Buy
+74,842
New +$40.4K ﹤0.01% 2888

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Mirae Asset Global ETFs Holdings's SGMO Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 3.8% in Q1 2026, buying an estimated $5.27K and bringing the position to 361,277 shares worth $89.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

Mirae Asset Global ETFs Holdings first reported a position in SGMO in Q2 2024 and has held it in 7 quarters since. The position peaked at $353K in Q4 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 361,277 shares of SANGAMO THERAPEUTICS INC worth $89.2K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 13,239 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $5.27K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2714 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's SANGAMO THERAPEUTICS INC position peaked at $353K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.